Paperpal Prime Logo

Minerva Medica : Impact Factor & More

eISSN: 1827-1669pISSN: 0026-4806

Key Metrics

CiteScore
5.7
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Medicine (all)
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Minerva Medica

Minerva Medica Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher EDIZIONI MINERVA MEDICA
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1921
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Minerva Medica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Minerva Medica

A phase III, randomized, double blind, controlled trial to evaluate the efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg, compared to diclofenac 75 mg monotherapy and placebo, in the treatment of acute low back pain.
  • 3 Aug 2026
  • Minerva medica
Celiac disease incidence after COVID-19 infection.
  • 3 Aug 2026
  • Minerva medica
Diagnostic accuracy of the Gugging Swallowing Screen and exploratory submental ultrasonographic findings in dysphagia screening for Parkinson disease: a retrospective cross-sectional study using videofluoroscopy as reference standard.
  • 27 Jul 2026
  • Minerva medica
Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.
  • 26 Jul 2026
  • Minerva medica
Hantavirus outbreak on a cruise ship: a lot of food for thought!
  • 20 Jul 2026
  • Minerva medica
MetALD-ALD patients: fate changes in relation to the specialist they meet.
  • 14 Jul 2026
  • Minerva medica
A phase III, randomized, double blind, controlled trial to evaluate the efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg, compared to diclofenac 75 mg monotherapy and placebo, in the treatment of acute low back pain.
  • 3 Aug 2026
  • Minerva medica
Celiac disease incidence after COVID-19 infection.
  • 3 Aug 2026
  • Minerva medica
Diagnostic accuracy of the Gugging Swallowing Screen and exploratory submental ultrasonographic findings in dysphagia screening for Parkinson disease: a retrospective cross-sectional study using videofluoroscopy as reference standard.
  • 27 Jul 2026
  • Minerva medica
Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.
  • 26 Jul 2026
  • Minerva medica
Hantavirus outbreak on a cruise ship: a lot of food for thought!
  • 20 Jul 2026
  • Minerva medica
MetALD-ALD patients: fate changes in relation to the specialist they meet.
  • 14 Jul 2026
  • Minerva medica

FAQs on Minerva Medica